sodium citrate, anhydrous has been researched along with refludan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kim, YG | 1 |
Graber, ML; Martinez, RM; O'Toole, GA; Sargent, JL; Shanks, RM | 1 |
Rolfes, C; Steinfeldt, T | 1 |
1 review(s) available for sodium citrate, anhydrous and refludan
Article | Year |
---|---|
Anticoagulation during haemodialysis in patients at high-risk of bleeding.
Topics: Anticoagulants; Cellulose; Citrates; Epoprostenol; Hemodialysis Solutions; Hemorrhage; Heparin; Heparin, Low-Molecular-Weight; Hirudins; Humans; Membranes, Artificial; Recombinant Proteins; Renal Dialysis; Risk Factors; Sodium Citrate | 2003 |
2 other study(ies) available for sodium citrate, anhydrous and refludan
Article | Year |
---|---|
Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces.
Topics: Anticoagulants; Bacteremia; Bacterial Adhesion; Biofilms; Catheterization; Catheters, Indwelling; Citrates; Dose-Response Relationship, Drug; Edetic Acid; Equipment Contamination; Gentamicins; Heparin, Low-Molecular-Weight; Hirudins; Polystyrenes; Polyurethanes; Recombinant Proteins; Silicone Elastomers; Sodium Citrate; Solutions; Staphylococcus aureus; Staphylococcus epidermidis; Tissue Plasminogen Activator | 2006 |
[Heparin induced thrombocytopenia and anticoagulation in renal replacemant therapy].
Topics: Acute Kidney Injury; Anticoagulants; Arginine; Blood Coagulation Tests; Chondroitin Sulfates; Citrates; Critical Care; Dermatan Sulfate; Diagnostic Errors; Dose-Response Relationship, Drug; Epoprostenol; Fondaparinux; Hemofiltration; Heparin; Heparin, Low-Molecular-Weight; Heparitin Sulfate; Hirudins; Humans; Iloprost; Pipecolic Acids; Polysaccharides; Recombinant Proteins; Sodium Citrate; Sulfonamides; Thrombocytopenia; Thrombosis | 2008 |